Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse-Reference-Cited by-同舟云学术

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse

Published:2014-03-07 Issue:4 Volume:89 Page:399-403
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Pilorge Sylvain¹,Rigaudeau Sophie¹,Rabian Florence¹,Sarkozy Clémentine¹,Taksin Anne L.¹,Farhat Hassan¹,Merabet Fathia¹,Ghez Stéphanie¹,Raggueneau Victoria²,Terré Christine²,Garcia Isabelle²,Renneville Aline³,Preudhomme Claude³,Castaigne Sylvie¹⁴,Rousselot Philippe¹⁴

Affiliation:

1. Service d'Hématologie et d'Oncologie; Hôpital André Mignot; Le Chesnay France

2. Département de Biologie Médicale; Hôpital André Mignot; Le Chesnay France

3. Laboratoire d'Hématologie, Centre de Biologie-Pathologie CHRU Lille, Université de Lille; Lille France

4. Université Versailles Saint-Quentin-en-Yvelines; Versailles France

Publisher

Wiley

Subject

Hematology

Reference36 articles.

1. Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group;Lee;Leukemia,2000

2. The treatment of acute myeloid leukemia in first relapse: A comprehensive review of the literature;Leopold;Leuk Lymph,2002